EVAX
EvaxionยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
EVAX Profile
Evaxion A/S
A clinical-stage biotech company developing AI-powered immunotherapies
Pharmaceutical
08/11/2008
02/05/2021
NASDAQ Stock Exchange
46
12-31
Depository Receipts (Ordinary Shares)
Dr. Neergaards Vej 5f DK-2970 Hoersholm, Denmark
--
Evaxion A/S was established on August 11, 2008 under the laws of the Kingdom of Denmark. The Company is a clinical-stage company that leverages its proprietary artificial intelligence or AI, technology, engineering expertise and drug development knowledge to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections.
